Analysis Metabolite Name Measured Value Units Cell Type Stimulation
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-1444Peak areaBS4 IL-17A
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-8039Peak areaHAHA IL-17A
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-8739Peak areaBS4 TNF-alpha
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-9171Peak areaBS4 Untreated
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-10106Peak areaPAK TNF-alpha
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-14786Peak areaPAK IFN-G
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-17379Peak areaHAHA TNF-alpha
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-22511Peak areaHAHA IFN-G
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-34055Peak areaPAK TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-Peak areaBS4 IFN-G
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-Peak areaBS4 TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-Peak areaHAHA TNF-alpha+IL-17A
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-Peak areaHAHA Untreated
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-Peak areaPAK IL-17A
Reversed phase NEGATIVE ION MODEBENZOATE (CAS# 65-85-0); (M-H)-Peak areaPAK Untreated

Return to search page
  logo